Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...